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Introduction
Spinal muscular atrophy (SMA) is a genetic disorder associated 
with recessive loss-of-function mutations in the human survival 
motor neurons 1 (SMN1) gene (Lefebvre et al., 1995). SMA is a 
broad-spectrum disorder whose severity is inversely propor-
tional to levels of full-length SMN protein (Nicole et al., 2002). 
The most severe form of SMA is also the most common one, 
and these patients typically die within the fi  rst 2 yr of life (Ogino 
and Wilson, 2004). SMA is characterized by loss of moto-
neurons from the anterior horn of the spinal cord and progres-
sive muscular atrophy in the limbs and trunk, usually culminating 
in respiratory failure (Ogino and Wilson, 2004).
SMN is the central member of a large oligomeric protein 
complex implicated in a variety of subcellular processes, in-
cluding pre-mRNA transcription and splicing, RNP biogenesis 
and transport, neuritogenesis, and axonal pathfi  nding, as well 
as in the formation and function of neuromuscular junctions 
(Briese et al., 2005; Eggert et al., 2006). However, the only 
SMN function that has been well-documented to date is its role 
in the biogenesis of Sm-class small nuclear RNPs (snRNPs; 
  Fischer et al., 1997; Meister et al., 2001; Pellizzoni et al., 2002). 
Despite the observation that SMA patient-derived SMN1 muta-
tions lead to defects in Sm-core assembly in vitro (Shpargel and 
Matera, 2005; Wan et al., 2005; Winkler et al., 2005), a defi  ni-
tive link between snRNP biogenesis and the etiology of the dis-
ease has not been established in a model organism.
Null mutations in single-copy SMN genes are lethal in 
  every organism studied to date (Monani, 2005). In humans and 
higher primates, there are two SMN genes, SMN1 and SMN2 
(Courseaux et al., 2003). SMN2 is dispensable, but can partially 
compensate for homozygous loss of SMN1 (Monani, 2005). 
  Patients with additional copies of SMN2 display milder pheno-
types, a fi  nding that has been confi  rmed using several transgenic 
mouse models (Monani, 2005). Because SMA is caused by re-
duced expression of SMN, modeling SMA in other genetically 
tractable organisms has been hampered by the need to create 
hypomorphic mutations. We describe the generation of a 
  Drosophila melanogaster model of SMA. Hypomorphic Smn 
mutants are characterized by an inability to fl  y or jump, and 
they display severe neuromuscular defects. The analysis of this 
phenotype has led to the surprising discovery that SMN is a 
  sarcomeric protein, implicating a muscle-specifi  c function.
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utations in human survival motor neurons 1 
(SMN1) cause spinal muscular atrophy (SMA) 
and are associated with defects in assembly of 
small nuclear ribonucleoproteins (snRNPs) in vitro. How-
ever, the etiological link between snRNPs and SMA is 
  unclear. We have developed a Drosophila melanogaster 
system to model SMA in vivo. Larval-lethal Smn-null mu-
tations show no detectable snRNP reduction, making it 
unlikely that these animals die from global snRNP depri-
vation. Hypomorphic mutations in Smn reduce dSMN 
protein levels in the adult thorax, causing ﬂ   ightlessness 
and acute muscular atrophy. Mutant ﬂ  ight muscle moto-
neurons display pronounced axon routing and arboriza-
tion defects. Moreover, Smn mutant myoﬁ  bers fail to form 
thin ﬁ  laments and phenocopy null mutations in Act88F, 
which is the ﬂ  ight muscle–speciﬁ  c actin isoform. In wild-
type muscles, dSMN colocalizes with sarcomeric actin 
and forms a complex with α-actinin, the thin ﬁ  lament 
crosslinker. The sarcomeric localization of Smn is con-
served in mouse myoﬁ  brils. These observations suggest 
a muscle-speciﬁ   c function for SMN and underline the 
importance of this tissue in modulating SMA severity.
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Results
D. melanogaster Smn functions 
in snRNP assembly
Smn (CG16725) is a single-exon gene in D. melanogaster (Fig. 
1 A), encoding a 226-aa protein (Miguel-Aliaga et al., 2000). 
The expression profi  le shows that dSMN is highly expressed 
during embryogenesis, but that the levels decrease sharply 
  during subsequent developmental stages (Fig. 1 B and not 
  depicted). Because SMN is essential for Sm-core RNP assem-
bly in human cells (Shpargel and Matera, 2005; Wan et al., 
2005; Winkler et al., 2005), we investigated whether the 
D.   melanogaster protein has a similar conserved function. 
  Schneider 2 (S2) cells treated with double-stranded RNA (dsRNA) 
targeting Smn, but not LacZ, were effi  ciently and specifi  cally 
depleted of dSMN (Fig. 1 C). As assayed by two independent 
methods, Smn dsRNA-treated S2 cells were defi  cient in assembly 
of new Sm cores (Figs. 1, D and E). Thus, we conclude that SMN’s 
function in snRNP assembly is conserved in invertebrates.
Characterization of Smn-null mutants
A previous study identifi  ed two missense mutations (Smn
A and 
Smn
B; Fig. 1 A) in the conserved Y-G box of the D.  melanogaster 
gene, the homozygous inheritance of which results in late-larval 
lethality (Chan et al., 2003). To identify additional alleles, we 
searched transposon insertion databases and found one P ele-
ment and two piggyBac transposon insertions in both coding 
and noncoding regions of Smn (Fig. 1 A). EY14384 (henceforth 
referred to as Smn
E) is a P insertion located 94 bp upstream of 
the putative transcription start site, whereas f05960 (Smn
C) and 
Figure 1.  Genomic architecture and allelic 
organization of the D. melanogaster Smn 
gene, and its role in snRNP assembly. 
(A) D. melanogaster Smn is a single-exon gene. 
Smn
73Ao (herein referred to as Smn
A) and Smn
B 
are missense mutations in the conserved Y-G 
box described previously (Chan et al., 2003). 
Transposon insertions are marked by open tri-
angles. Smn
C and Smn
D are piggyBac inser-
tions at +407 and +58 bp from the translation 
start, respectively. Smn
E is a P element inser-
tion at −94 bp, which is upstream of the puta-
tive transcription start site. Smn
E2 and Smn
E33 
are imprecise excision alleles derived from the 
mobilization of Smn
E. (B) Western blot of em-
bryonic and adult lysates. A dilution series of 
the embryonic lysate indicated that adults have 
 30-fold less dSMN than embryos. Anti-SNF 
antibody was used as the loading control. 
(C) S2 cells were left untreated (Mock) or incu-
bated with dsRNAs targeting either LacZ or 
Smn. Cytoplasmic extracts were collected 3 d 
after treatment, and Western blotting con-
ﬁ  rmed  efﬁ   cient knockdown of dSMN com-
pared with the loading control. (D) Radiolabeled 
U1 snRNA transcripts were incubated in cyto-
plasmic extracts and immunoprecipitated with 
α-Sm monoclonal antibody Y12 to assay for 
Sm-core assembly. Incubations of wild-type U1 
snRNA (+) at the nonpermissive temperature 
(4°C) or a U1 construct containing a deletion 
in the Sm protein binding site (∆) at the permis-
sive temperature (22°C) served as the negative 
controls. RNAi knockdown of dSMN signiﬁ  -
cantly disrupted Sm-core assembly compared 
with mock and LacZ dsRNA transfections. 
(E) After dsRNA treatment for 6 d (two doses 
of dsRNA), S2 cells were transfected with 
  either GFP alone or GFP-SmB. Immunoprecipi-
tation using anti-GFP antibodies, followed by 
  Northern analysis of U1 and U2 snRNAs, indi-
cated that GFP alone did not bring down 
  detectable amounts of snRNA, the amounts 
  immunoprecipitated by GFP-SmB after RNAi 
knockdown of dSMN were at least twofold 
less than in the control (LacZ) knockdown. 
(F) Expression proﬁ   le of dSMN in the lethal 
  alleles described in A. All of the lethal alleles are essentially protein nulls, although residual levels of dSMN in lysates derived from the Smn
A and Smn
B 
  alleles varied from preparation to preparation (not depicted). Anti-SNF antibody was used as the loading control. We note that wild-type embryonic lysates 
were competent for the Sm-core assembly assay shown in D, but larval, pupal, and adult lysates were incompetent, which is consistent with previous results 
from other species (Gabanella et al., 2005; Wan et al., 2005). (G) Northern blot of total larval RNAs from wild-type (WT), Smn
C homozygous (Smn
C), or 
heterozygous (Het
C) mutants. 2 μg of RNA were loaded in each lane; comparable levels of U1, U2, and U4 snRNAs were detected (U3 was used as a 
  control). Molecular weight markers are in kilodaltons.A D. MELANOGASTER MODEL OF SMA • RAJENDRA ET AL. 833
f01109 (Smn
D) are piggyBac insertions within the coding re-
gion. Developmental analysis of these mutants demonstrated 
that Smn
E homozygotes are completely viable, with no apparent 
phenotype. The Smn
C and Smn
D alleles are late-larval lethals. 
Genetic complementation studies revealed that the A-D alleles 
failed to complement each other, and that crossing them over 
appropriate deletions did not accelerate the lethal phase. 
  Importantly, transgenic expression of a UAS-YFP-Smn con-
struct under control of a daughterless-GAL4 driver completely 
rescued the larval lethality of the two alleles we tested,  producing 
viable adults. Thus, the A-D alleles are genetic-null mutants. 
Consistent with these genetic results, Western blotting of  lysates 
from the phenocritical phase (second to third instar) indicated 
a complete loss of dSMN protein (Fig. 1 F and not depicted). 
However, despite the loss of dSMN, we could detect no appre-
ciable differences in spliceosomal snRNA levels in the mutant 
larvae (Fig. 1 G and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200610053/DC1). These fi  ndings are similar to 
those of Wan et al. (2005), which showed that reduced SMN 
  expression and impaired snRNP synthesis caused a slow growth 
phenotype, but did not affect steady-state snRNP levels in 
chicken DT40 cells. Thus, despite the observation that dSMN 
functions in snRNP biogenesis in D. melanogaster, the lethality 
associated with the null mutants is not caused by a systemic 
  depletion of snRNPs.
Smn hypomorphs: a model for SMA 
in the adult ﬂ  y
SMA is caused by reduced levels of SMN in mammals; com-
plete loss of function results in early lethality (Monani, 2005). 
To generate a better D. melanogaster model for SMA, we 
screened for neuromuscular phenotypes in adult fl  ies by impre-
cise excision of the P element in Smn
E. From a total of  170 
independent excisions, we isolated two lines (Smn
E2 and Smn
E33) 
that displayed overt motor dysfunction. Smn
E2 and Smn
E33 ho-
mozygotes (henceforth referred to as E2 and E33 mutants, re-
spectively) each showed marked defects in fl  ying and jumping. 
The E2 mutants exhibited a 2-d delay in pupation, refl  ecting an 
extended larval period, and  20% of the E2 pupae died at the 
pharate adult stage. However, the phenotype of the E2 mutants 
was incompletely penetrant;  45% of E2 animals had fl  ight 
and jump defects. Moreover, dSMN expression levels in these 
animals were also variable (unpublished data). In contrast, E33 
mutants were completely viable and fertile, and 100% of the ani-
mals were incapable of fl  ying or jumping (Videos 1 and 2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200610053/DC1). 
Because the E33 phenotype was fully penetrant, this   allele was 
chosen for further characterization.
The indirect fl  ight muscles (IFMs) of the D. melanogaster 
thorax are among the best characterized muscles in the adult 
animal and are essential for fl  ight (Fernandes and Keshishian, 
1999). Because E33 mutants are fl  ightless, we prepared hemi-
thoraces by dissection and analyzed the IFMs of wild-type and 
mutant animals by light microscopy. The IFMs of the fruitfl  y 
are composed of dorsal longitudinal muscles (DLMs) and 
  dorsoventral muscles (DVMs). The mutant IFMs were highly 
disorganized, even when observed at a gross level (Fig. 2 A). 
Although DLM fi  bers in wild-type fl  ies span the entire antero-
posterior length of the dorsal thorax, E33 DLMs often failed to 
extend the whole length of the thorax, and DVMs were typically 
unidentifi  able (Fig. 2 A). When salicylate-cleared thoraces were 
imaged under plane-polarized light, signifi  cant muscle de-
generation was apparent in the mutant fi  bers (Fig. 2 B). Under 
higher magnifi  cation, wild-type IFMs showed the characteristic 
Figure 2.  Phenotypic analysis of Smn
E33 hypomorphs. (A) Light micro-
scopic analysis of hemithoraces from 2–3-d-old wild-type (WT, left) and 
E33 mutant IFMs showed considerable disorganization of muscle ﬁ  bers 
(middle and right). (B) Thoraces were visualized under plane-polarized op-
tics after clearing in methylsalicylate. The IFMs consist of two groups, the 
DLMs and the DVMs. DLMs run from anterior to posterior on the dorsal side 
of the thorax, and DVMs run dorsoventrally, nearly perpendicular to the 
DLMs. Wild-type muscles appear normal (left), including the tergal depres-
sor of the trochanter (jump) muscle, outlined in white and below the plane 
of the DLMs. Mutant ﬁ   bers showed clear signs of degeneration (dark 
patches within the muscle). Both DLMs and DVMs were equally and se-
verely affected; however, the jump muscles displayed normal (center) to se-
vere (right) degeneration phenotypes. (C) Higher magniﬁ   cation view of 
wild-type (WT) and E33 mutant DLMs showing striations in the wild type 
that are absent from the mutant myoﬁ  bers. (D and E) Western blotting of 
dSMN from embryonic, pupal, total adult, or total adult thoracic lysates. 
Although no major differences in dSMN levels were detected in the total 
lysates at any of the developmental stages, dSMN was markedly reduced 
in E33 mutant thoraces (two different preparations are shown) compared 
with either wild type or the parental Smn
E line. Antibodies against SmB 
(Y12) and SNF were used as loading controls. Molecular weight markers 
are in kilodaltons.JCB • VOLUME 176 • NUMBER 6 • 2007  834
striations, whereas the mutant muscles were extremely irregu-
lar, with numerous bulges and constrictions throughout (Fig. 
2 C). Thus, E33 mutants display severe muscular atrophy, which 
is one of the hallmark features of SMA.
Genetic complementation analyses revealed that the loss-
of-function (null) alleles, described in the previous section (Fig. 
1 A), each failed to complement the motor dysfunction pheno-
type of the E33 allele. Furthermore, the fl  ightlessness of the E33 
mutation was rescued by expression of the UAS-YFP-Smn 
transgene under the control of a daughterless-GAL4 driver, 
demonstrating that the observed motor defects in E33 are, 
  indeed, caused by loss of dSMN function. Therefore, we were 
somewhat surprised when we analyzed developmentally staged 
lysates by Western blotting of dSMN and found no appreciable 
differences between adult wild-type and E33 mutants (Fig. 
2 D). Upon further analysis, we found that the amount of dSMN 
produced in the mutant thoraces was substantially reduced 
relative to either wild-type or Smn
E parental lines (Fig. 2 E). 
Although the reason for this tissue-specifi  c depletion is cur-
rently unknown, the mutants presented us with an opportunity 
to analyze the neuromuscular defects associated with reduced 
dSMN expression.
During the embryonic–larval transition, D. melanogaster 
motoneurons contact muscle fi  bers only after the completion of 
myogenesis (Johansen et al., 1989). In contrast, adult motoneu-
rons establish contact with the developing muscle fi  bers during 
myogenesis, which is a situation more akin to that of vertebrate 
development (Fernandes and Keshishian, 1999). Fruitfl  y DLMs 
are innervated by remodeled larval motoneurons whose cell 
bodies lie within the thoracic ganglion and project dorsally into 
the fl  ight muscles (Fernandes and Keshishian, 1999). Using 
monoclonal antibody 22C10, which stains neuronal processes 
(Patel, 1994), we analyzed the DLMs of E33 hypomorphs for 
defects in the organization of their DLM motoneurons. As 
shown in Fig. 3, both the number and routing of primary moto-
neuron branches was clearly compromised in E33 fl  ies, as com-
pared with controls. Secondary branches were disorganized 
(Fig. 3) and arborization defects ranged from moderate to 
  severe. Because the mutant muscle fi  bers were spatially dis-
organized, it was diffi  cult to assign parameters to the individual 
motoneurons. Using criteria established by Hebbar and 
 Fernandes (2004) as a guide, we scored fl  ies from each  genotype 
and found that  80% of the mutant thoraces showed moto-
neuron routing defects; a smaller fraction ( 40%) showed de-
fects in secondary branching and arborization. No such defects 
were observed in the control animals. Thus, we conclude that 
reduced thoracic Smn expression leads to acute neuromuscular 
dysfunction in D. melanogaster.
Smn is required for Actin88F expression
The development of muscles and motoneurons in the adult fruit-
fl  y are spatiotemporally associated. In other words, the synthe-
sis of structural proteins important for one tissue can require the 
presence of the other tissue. For example, formation of the 
male-specifi  c muscle (MSM) and the development of its spe-
cialized characteristics are absolutely dependent on innervation 
Figure 3.  DLM motoneuron organization in E33 
mutants. (A) Schematic of motoneuron branching 
pattern in adult DLMs. Primary branches (1°) grow 
out from the main nerve trunk (N) that traverses the 
length of the six adult DLM ﬁ  bers. Defasciculation 
of primary branches leads to establishment of sec-
ondary (2°) and tertiary (3°) branches, which 
  develop the terminal arbor (not depicted). DLM 
motoneurons were stained with monoclonal anti-
body 22C10, which stains neuronal processes. 
Organization of primary branches in both the 
wild-type and the parental Smn
E animals appeared 
normal. The number and routing of primary moto-
neuron branches were severely compromised in 
E33 ﬂ  ies. (B) Quantitation of routing and branch-
ing defects in wild-type and mutant DLMs. Primary 
branches that displayed a meandering path were 
taken as having routing defects. Motoneurons dis-
playing fewer than three secondary branches 
were scored as having a secondary branching 
defect (wild-type animals display a minimum of 
four to ﬁ  ve secondary branches). 90 hemithora-
ces (from 90 individual ﬂ   ies) of each genotype 
were scored.A D. MELANOGASTER MODEL OF SMA • RAJENDRA ET AL. 835
(Currie and Bate, 1995). Furthermore, expression of an MSM-
specifi  c actin isoform, Act79B, is also dependent on innervation 
(Currie and Bate, 1995). Similarly, in vertebrates, denervation 
is known to result in reduced expression of skeletal muscle actin 
(Shimizu et al., 1988). Given that SMA is characterized by moto-
neuron denervation, it seemed likely that the neuromuscular 
  defects observed in the E33 hypomorphs was also coupled with 
innervation failure. Because one of the hallmarks of innervation 
failure is reduced expression of actin, we tested whether the 
IFM-specifi  c actin isoform Act88F (Fyrberg et al., 1983) was 
expressed in the Smn hypomorphs. RT-PCR was performed on 
thoracic RNA from wild-type, Smn
E, and E33 animals, using 
primers specifi  c for Act88F, Tropomyosin 2 (Tm2), and Troponin I 
(TnI) transcripts. Expression of Act88F was undetectable in the 
mutant thoraces, whereas the transcripts were easily detected in 
the wild-type and Smn
E strains (Fig. 4 A). We note that loss of 
Act88F expression was not caused by a general loss of tran-
scription or splicing in the IFMs, as the RT-PCR products for 
TnI and Tm2 (which cross intron–exon boundaries) were com-
parable in all three samples (Fig. 4 A). Consistent with the idea 
that splicing is unaffected in the mutants, Northern analysis of 
thoracic lysates from wild-type or E33 fl  ies showed no sig-
nifi  cant differences in steady-state levels of either snRNAs 
(Fig. 4 B) or trimethylguanosine-capped snRNPs (Fig. S1). 
Staining of wild-type (Fig. 4 C) and mutant (Fig. 4 D) muscles 
with phalloidin confi  rmed the general loss of fi  lamentous actin 
in the hypomorphic IFMs. Most importantly, actin staining and 
proper myofi  bril formation were rescued by transgenic expres-
sion of YFP-dSMN (Fig. 4 E). Thus, reduced levels of dSMN 
protein result in loss of Act88F expression and severe neuro-
muscular disorganization.
SMN interacts with 𝗂-actinin
In a parallel set of experiments, we were interested in purifying 
and characterizing the D. melanogaster SMN complex. After 
transient transfection of S2 cells with a Flag-dSMN construct, 
we performed a pulldown experiment with anti-Flag beads. 
Associated proteins were eluted from the beads by boiling in 
sample buffer and subjected to SDS-PAGE. The protein profi  les 
of transfected versus nontransfected cells were compared by 
Figure 4.  Thin, but not thick, ﬁ  lament formation is compromised in E33 
mutant IFMs. (A) RT-PCR analysis of IFM-speciﬁ  c actin (Act88F) expression; 
transcripts were not detectable in E33 mutants, whereas expression was 
normal in the wild-type (WT) and the parental Smn
E alleles. Troponin I (TnI) 
and tropomyosin 2 (Tm2) RT-PCR products served as internal controls. 
(B) Northern blot of total thoracic RNA from adult wild-type (WT) or E33 
mutants shows that steady-state U1 and U2 snRNA levels are normal. U3 
and U6 snRNA levels used as loading controls. 2 μg of total RNA were 
loaded in each lane. (C–E) Loss of actin expression was conﬁ  rmed in E33 
mutant myoﬁ  bers using phalloidin. Whereas the characteristic repetitive 
blocks of actin were observed in wild-type (WT) myoﬁ  brils (c), no stain-
ing was detected in the mutant (d). Actin staining in the E33 mutants was 
restored by transgenic expression of YFP-dSMN (E). Molecular weight 
markers in base pairs. 
Figure 5.  D. melanogaster SMN forms a complex with 𝗂-actinin. (A) Flag-
dSMN was transiently transfected into S2 cells and puriﬁ  ed over anti-FLAG 
beads. Eluted proteins were subjected to SDS-PAGE and Coomassie stain-
ing. Untransfected cells were used as a negative control. The three marked 
bands were excised from the gel and identiﬁ  ed by mass spectrometry as 
  α-actinin, Flag-dSMN, and dSMN, respectively. (B) Pulldown assays with 
GST-dSMN or GST alone were performed using total adult lysates. The 
pulldowns were assayed by Western blotting with monoclonal α-actinin 
antibodies. Polyclonal anti-GST antibodies were used for the loading con-
trols. (C) Proteins were coimmunoprecipitated from adult thoracic lysates 
with dSMN antibodies and analyzed by Western blotting with α-actinin 
antibodies. Molecular weight markers in kilodaltons.JCB • VOLUME 176 • NUMBER 6 • 2007  836
Coomassie staining (Fig. 5 A). Although a more detailed analy-
sis (unpublished data) suggests that there are likely to be many 
other differences between the two samples, three prominent 
bands could be easily distinguished. The bands were excised 
from the gel and analyzed by mass spectrometry. The two 
smaller proteins were identifi  ed as Flag-dSMN and endogenous 
dSMN (Fig. 5 A and not depicted). Because SMN is known to 
self-oligomerize (Lorson et al., 1998), we expected to recover 
the endogenous dSMN protein. However, the third,  100-kD 
band was identifi  ed by 39 distinct peptides in the mass spectro-
gram as D. melanogaster α-actinin (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200610053/DC1).
Because α-actinin is a protein known to play a major role 
in cross-linking actin fi  laments within numerous cell types, in-
cluding muscle (Clark et al., 2002), we tested whether dSMN 
interacts with α-actinin in additional biochemical assays. We 
performed GST-pulldown and coimmunoprecipitation analyses 
using adult and thoracic lysates. Fig. 5 B shows that α-actinin 
was recovered using GST-dSMN, but not with GST alone (con-
trol). As shown in Fig. 5 C, anti-dSMN antibodies weakly, but 
reproducibly, coprecipitated α-actinin. Control (anti-myc) anti-
bodies and beads coprecipitated only background amounts of 
α-actinin. Collectively, these studies show that dSMN forms a 
complex with α-actinin in vivo.
SMN localizes to IFM myoﬁ  brils
Given the aforementioned fi  ndings, we analyzed the localiza-
tion of dSMN in the IFMs of wild-type and YFP-dSMN trans-
genic fl  ies (Fig. 6). Each IFM myofi  ber is a single multinucleate 
cell composed of several myofi  brils that contain numerous 
functional units called sarcomeres. Within each sarcomere, 
  actin (thin) and myosin (thick) fi  laments interdigitate to form 
contractile elements. Thick fi  laments are anchored together within 
a structure known as the M-line, whereas thin fi  laments are an-
chored at the Z-line or Z-disc (Clark et al., 2002). The region 
between the M-lines is called the I-band. Actin is typically 
  excluded from the M-line, localizing throughout the I-band, and 
it is often enriched at, or depleted from, the Z-line.
In wild-type and YFP-dSMN transgenic myofi  bers, dSMN 
was detected not only in muscle cell nuclei but also in the indi-
vidual myofi  brils (Fig. 6, E and F; and not depicted). Within the 
myofi   brils, three distinct patterns of sarcomeric localization 
were observed: I-band, Z-line enriched, and granular (Fig. 6, 
A–C). The same three SMN localization patterns were visible in 
IFM myofi  brils from YFP-dSMN transgenic fl  ies (Fig. 6, J–L). 
The I-band pattern was the predominant one, as confi  rmed by 
phalloidin costaining (Fig. 6, G–I). However, the dSMN and 
  actin staining patterns did not always correlate, especially in 
  respect to accumulation at the Z-line. That is, when actin was 
Figure 6.  Sarcomeric localization of dSMN in wild-type and 
YFP-dSMN transgenic IFM myoﬁ  brils.  (A–C) Three patterns of 
dSMN localization (I-band [A], Z-line enriched [B], and granular 
[C]) were observed using afﬁ  nity-puriﬁ  ed anti-dSMN antibodies. 
(D) Control image using secondary antibody only (2° only). 
(E and F) Control images showing that dSMN localizes to both 
nuclei and myoﬁ  brils, whereas anti-SNF (a spliceosomal protein) 
antibodies stain only nuclei. (G–I) Costaining of dSMN (red, G) 
and ﬁ  lamentous actin (green, H) showing dSMN in the I-band 
pattern. Merged image shown in I. (J–L) The same three patterns 
observed in A–C were also found in transgenic ﬂ  ies expressing 
YFP-dSMN (red). (M) Control image of myoﬁ  brils from transgenic 
ﬂ  ies expressing 2xYFP. (N and O) Wild-type myoﬁ  brils showing 
colocalization of dSMN (N) with the Z-line marker α-actinin (O).A D. MELANOGASTER MODEL OF SMA • RAJENDRA ET AL. 837
enriched at the Z-line, dSMN did not necessarily show a similar 
enrichment, and vice versa. It is possible that dSMN localiza-
tion within the sarcomere is dynamic; future experiments will 
be required to address this point. Meanwhile, control antibodies 
and secondary antibodies alone clearly failed to stain the sarco-
meres (Fig. 6, D and F). Similarly, a 2xYFP transgene construct 
showed only background staining in the myofi  brils (Fig. 6 M). 
Importantly, in myofi  brils where dSMN was enriched at the 
Z-line, it colocalized with α-actinin (Fig. 6, N and O). We con-
clude that dSMN localizes to fl  ight muscle sarcomeres.
Smn hypomorphs phenocopy 
Act88F-null mutants
The studies detailed in the previous sections suggested that the 
fl  ightlessness associated with the Smn
E33 allele might be caused 
by a loss of actin expression in the IFMs. Therefore, we exam-
ined the IFMs of fl  ies that contain a null mutation in Act88F 
(Okamoto et al., 1986), which is called KM88. Like Smn
E33 mu-
tants, Act88F
KM88 homozygotes are fl  ightless and fail to form proper 
IFMs, but are otherwise viable and fertile (Okamoto et al., 
1986). As shown in Fig. 7 A, KM88 mutants express dSMN, but 
the protein is delocalized. Similarly, α-actinin, an actin fi  lament 
cross-linking factor (Otey and Carpen, 2004), was mislocalized 
in both the Smn and the Act88F mutant backgrounds, which is 
consistent with a complete failure to form thin fi  laments.
Further analysis demonstrated that thick fi  lament forma-
tion was largely unperturbed in the Smn hypomorphic IFMs, 
and that α-actinin staining did not overlap with the myosin fi  la-
ments (Fig. 7 B). This scenario is, again, very similar to that of 
the KM88 mutation, wherein the vast majority of myosin-
 positive  fi  laments are devoid of α-actinin (unpublished data). 
Collectively, these fi  ndings indicate that dSMN and Act88F are 
required for proper formation of fl  ight-muscle myofi  brils.
Smn localization to sarcomeres 
is evolutionarily conserved
To determine whether the sarcomeric localization of SMN is a 
conserved feature among vertebrates, we prepared myofi  brils 
from mouse hindlimb muscles and analyzed the distribution of 
Smn and α-actinin. As shown in Fig. 8, Smn colocalizes with 
α-actinin in a Z-line pattern. Two independent anti-SMN anti-
bodies revealed the same pattern, and control antibodies were 
negative (Fig. 8). Unlike the situation in the fl  y, mouse Smn 
  localized exclusively to the Z-line; no granular or I-band like 
patterns were observed.
In summary, four lines of evidence demonstrate that SMN 
is a bona fi  de sarcomeric protein. First, localization to the sarco-
mere was not simply caused by cross-reactivity of the  antibodies, 
as transgenic expression of YFP-dSMN showed pro  minent 
myofi   brillar staining that was completely absent in control 
IFMs (Fig. 6). Second, control antibodies fail to stain the sar-
comeres of both fl  ies and mice (Figs. 6 and 8). Third, dSMN 
  staining was lost in the E33 mutants, resulting in a loss of 
Act88F expression and thin fi  lament formation (Fig. 4). Fourth, 
dSMN interacts with α-actinin in vitro and in vivo (Fig. 5), and 
reduced dSMN expression leads to complete disorganization of 
α-actinin in situ (Fig. 7 B). Thus, we conclude that SMN is a 
sarcomeric protein.
Discussion
SMN and the etiology of SMA
Despite the well-established gene–disease relationship between 
SMN1 and SMA, the connection between protein function and 
molecular etiology has been obscured by a plethora of putative 
cellular functions attributed to SMN (Briese et al., 2005; Eggert 
et al., 2006). Previous investigations have shown that the SMN 
Figure 7.  Localization of dSMN, 𝗂-actinin, and myosin 
in wild-type and mutant IFM myoﬁ  brils.  (A) Wild-type 
(WT, left), Smn hypomorphic (E33, middle), and Act88F-
null mutant (KM88, right) myoﬁ   bers were stained with 
anti-dSMN (top) or α-actinin (bottom) antibodies. (B) Stain-
ing with α-actinin (red) and myosin (green) antibodies 
showing thin ﬁ   lament formation is disrupted in E33 
  mutants (bottom) compared with wild-type controls (top). 
Thick ﬁ   laments (green) were detectable in the mutant 
  myoﬁ  bers (bottom).JCB • VOLUME 176 • NUMBER 6 • 2007  838
complex is required for assembly and transport of spliceosomal 
snRNPs (Fischer et al., 1997; Meister et al., 2001; Pellizzoni 
et al., 2002; Narayanan et al., 2004; Shpargel and Matera, 2005). 
Additional fi  ndings point to roles for this complex in neurite 
outgrowth and pathfi  nding (Fan and Simard, 2002; McWhorter 
et al., 2003; Sharma et al., 2005), neuromuscular junction for-
mation (Chan et al., 2003), profi  lin binding (Giesemann et al., 
1999; Sharma et al., 2005), and axonal transport of β-actin 
mRNPs (Rossoll et al., 2003). A common link between each of 
these additional studies is the actin cytoskeleton. Our fi  nding 
that reduced dSMN expression leads to motor axon routing and 
arborization defects, coupled with a loss of Act88F expression 
in the muscle, is consistent with this actin-related theme.
A muscle-speciﬁ  c function for SMN
The vast majority of SMA studies continue to be focused on a 
motoneuron-specifi  c role for SMN; our results do not exclude 
such a function. However, the idea that SMN might also have a 
muscle-specifi  c function is not a new one. Cocultures of SMA 
type I and II muscles with wild-type motoneurons failed to sus-
tain innervation, whereas muscles from control or SMA type III 
patients maintained stable connections, suggesting a muscle-
specifi  c requirement for SMN (Braun et al., 1995; Guettier-
 Sigrist et al., 2002). Similarly, down-regulation of Smn in mouse 
C2C12 cells revealed defects in myoblast fusion (Shafey et al., 
2005) and tissue-specifi  c knockouts of Smn in mouse muscle 
resulted in pronounced dystrophic phenotypes (Cifuentes-Diaz 
et al., 2001; Nicole et al., 2003). Also in support of a muscle-
specifi  c function is the observation that, despite having compa-
rable levels of SMN, mouse skeletal muscle extracts failed to 
support effi  cient Sm-core assembly, whereas extracts from spi-
nal cord were quite active (Gabanella et al., 2005). Collectively, 
these studies show that relatively high levels of SMN are 
  required in muscles, although the reason for this requirement 
was unclear.
Our discovery that SMN is a sarcomeric protein required 
for expression of muscle-specifi  c actin not only provides a plaus-
ible role for the protein in muscles, but highlights the potential 
importance of this tissue in SMA pathophysiology. At least 20 
different skeletal muscle diseases are thought to be caused by 
mutation or mislocalization of sarcomeric proteins (Sarnat, 
1992; Hauser et al., 2000; Moreira et al., 2000; Selcen and 
 Engel, 2003; Laing and Nowak, 2005). In this regard, it is parti cu-
larly interesting that SMA patients have been shown to display 
varying degrees of myofi  brillar/sarcomeric (including Z-line) 
abnormalities (Szliwowski and Drochmans, 1975; Braun et al., 
1995). Notably, αB-crystallin was recently reported to form a 
complex with SMN in HeLa cells (den Engelsman et al., 2005). 
αB-crystallin is an intermediate fi  lament protein that, in muscle 
cells, accumulates at the Z-line (Laing and Nowak, 2005). Thus, 
the SMN complex can interact with at least two distinct Z-line 
proteins, α-actinin, and αB-crystallin.
We have shown that reduced thoracic dSMN levels result 
in loss of Act88F expression with no apparent defect in either 
snRNP biogenesis or pre-mRNA splicing. Because expression 
of muscle-specifi  c actin is known to be dependent on moto-
neuron innervation (Shimizu et al., 1988; Currie and Bate, 
1995), the neuronal defects observed in the Smn
E33 hypomorphs 
are consistent with those expected of an SMA model. Further, 
the data are consistent with denervation as either the cause or a 
consequence of muscle degeneration. Notably, a fraction of 
SMA type III patients display dystrophic phenotypes with-
out evidence of neurogenic abnormalities (Szliwowski and 
  Drochmans, 1975; Vajsar et al., 1998; Muqit et al., 2004). 
  Although motoneuron loss is generally regarded as a late 
event in disease progression, one of the main problems in study-
ing SMA, especially the severe forms, is that we are only able 
to analyze the end-stage of the disease.
We currently do not know whether the mutant phenotype 
observed in the Smn hypomorphs is caused by reduced dSMN 
Figure 8.  The sarcomeric localization of SMN is con-
served in mouse myoﬁ  brils. (A) SMN localizes in a stri-
ated pattern in puriﬁ  ed mouse skeletal muscle myoﬁ  brils 
(red, left); the secondary antibody alone (goat anti–mouse 
Alexa Fluor 594) did not give a speciﬁ  c signal (red, right). 
(B) The Z-line marker protein, α-actinin (red, center), co-
localizes with SMN, as revealed by FITC-conjugated anti-
SMN primary antibodies (green, left). (C) As another 
negative control, an antibody against spliceosomal pro-
tein U2B′′ (center, red) showed only faint background 
staining. Myoﬁ   brils were counterstained for actin using 
FITC-conjugated phalloidin (green, left). (B and C) Merged 
images are shown on the right.A D. MELANOGASTER MODEL OF SMA • RAJENDRA ET AL. 839
expression in the thoracic muscles, the motoneurons, or a com-
bination of tissues. Future work using tissue-specifi  c rescue 
constructs and a detailed analysis of motoneuron development 
and myogenesis in the Smn hypomorphic pupae will address 
these important issues. Regardless of the actual disease trigger, 
the identifi  cation of SMN as a sarcomeric protein underscores 
the importance of muscle cell function in modulating the sever-
ity of SMA.
Materials and methods
Fly stocks and genetics
Oregon-R was used as the wild-type allele. Missense alleles Smn
A and 
Smn
B were gifts from M. van den Heuvel (Oxford University, Oxford, UK). 
Transposon insertion alleles Smn
C (f05960) and Smn
D (f01109) were ob-
tained from the Exelixis collection at Harvard Medical School. Smn
E 
(EY14384) was a gift from H. Bellen (Baylor College of Medicine,   Houston, 
TX; Bellen et al., 2004). Excision alleles were generated by mobilization of 
the Smn
E P element using standard protocols. KM88 was a gift from J. Vig-
oreaux (University of Vermont, Burlington, VT). All stocks were cultured on 
standard cream-of-wheat agar at room temperature (24 ± 1°C) in half-pint 
bottles. Genetic complementation analyses were performed using standard 
methods. UAS-2xEYFP, which was used as control for nonspeciﬁ  c localiza-
tion, and the daughterless-Gal4 (da-Gal4) lines were obtained from the 
Bloomington Stock Center. For rescue experiments, a YFP-dSMN transgene 
(a gift from J. Gall, Carnegie Institution of Washington, Baltimore, MD) 
was expressed under the control of da-Gal4 in the following homozygous 
backgrounds: Smn
E33, Smn
A, and Smn
B.
Western blotting
Embryonic, larval, adult (total and thoracic), and S2 cell lysates were pre-
pared, electrophoresed, and blotted using standard protocols. Anti–rabbit 
dSMN antibody (a gift from J. Zhou, University of Massachussetts Medical 
School, Worcester, MA) was afﬁ  nity-puriﬁ   ed and used at a dilution of 
1:10,000. Antibodies against SNF (4G3, monoclonal), SmB (Y12, monoclo-
nal), and tubulin (anti–rabbit; Sigma-Aldrich) were used as loading controls. 
Appropriate HRP-conjugated secondary antibodies were used for detection.
snRNP assembly assay
Smn and LacZ dsRNAs were transcribed in vitro from PCR products ﬂ  anked 
with T7 promoters. D. melanogaster S2 cells were placed in SF-900 media 
containing 14 μg/ml of dsRNA. Extracts were generated 3 d after dsRNA 
treatment using the Ne-Per nuclear/cytoplasmic extraction kit (Pierce 
Chemical Co.) and dialyzed in reconstitution buffer (20 mM Hepes-KOH, 
pH 7.9, 50 mM KCl, 5 mM MgCl2, and 0.2 mM EDTA) as previously de-
scribed (Pellizzoni et al., 2002). 40 μg of cytoplasmic extract were loaded 
on a gel for Western blotting to conﬁ   rm knockdown. For the assembly 
  assay, wild-type D. melanogaster U1 snRNA and U1 snRNA containing a 
deletion of the Sm assembly site were in vitro transcribed from PCR products 
in the presence of [
32P]UTP and m7G cap analogue (Promega). 100,000 
counts of radiolabeled U1 snRNA were incubated in 100 μg of cytoplas-
mic extract at 22°C for 40 min in reconstitution buffer. Assembled snRNPs 
were precleared with protein G beads before immunoprecipitation with 
monoclonal antibody Y12 in RSB-100 buffer (600 mM NaCl, 20 mM 
Tris-HCl, pH 7.4, 2.5 mM MgCl2, and 0.01% NP-40; Pellizzoni et al., 
2002). Immunoprecipitated RNAs were denatured in formamide load-
ing buffer, run on a 6% acrylamide TBE-urea gel, and exposed to 
a phosphorimager.
GST pulldown assay
GST-dSMN was cloned as previously described (Ilangovan et al., 2003). 
Total ﬂ  y lysate was homogenized in NET buffer (150 mM NaCl, 50 mM 
Tris, pH 7.5, and 5 mM EDTA). 500 μg of lysate was passed over recom-
binant 8 μg GST or GST-dSMN beads overnight in NET buffer. The pull-
down products were washed and loaded on a denaturing gel.
IP-Northern
15 μg of dsRNA against Smn or LacZ (control) were added twice to S2 cell 
medium over a course of 6 d. After knockdown, cells were transfected with 
GFP-SmB. Northern blotting of GFP-SmB immunoprecipitate using radio-
labeled D. melanogaster U1 and U2 snRNA probes was performed follow-
ing established protocols.
Northern blotting
Total RNA from adult thoraces was extracted using TRIZOL (Invitrogen). 
Adult thoraces were pulled apart from the main body, and wings and legs 
were clipped close to the thorax. Thoraces were immediately transferred to 
TRIZOL and homogenized. Total RNA was extracted following the manu-
facturer’s instructions. RNA was run on a standard 10% polyacrylamide-
urea gel (Invitrogen), transferred to a nylon membrane, and probed with 
32P-labeled PCR products corresponding to the D. melanogaster U1, U2, 
and U6 snRNAs and U3 snoRNA.
RT-PCR
Total RNA from adult thoraces was prepared as described in the previous 
section. RT-PCR, with appropriate controls, was performed using Super-
Script First-Strand synthesis system (Invitrogen). In brief, oligo-dT–primed 
ﬁ  rst-strand synthesis products were subjected to 20 cycles of PCR using 
gene-speciﬁ  c primers. Sequences are as follows: Act88F, sense 5′-C  C  A-
C  G  C  C  A  T  T  C  T  G  C  G  T  C  T  G  G  -3′ and antisense 3′-G  C  T  G  C  C  T  T  T  G  A  A  G  A  G-
C  T  T  T  C  G  C  G  -3′; troponin I, sense 5′-T  T  G  T  G  A  A  G  G  C  C  A  G  A  A  A  T  G  G  G  -3′ 
and antisense 5′-G  A  C  T  T  C  A  T  T  T  C  T  G  A  T  C  A  A  A  T  -CCAT; and tropomyosin 
2, sense 5′-C  A  C  C  A  T  G  G  A  C  G  C  C  A  T  C  A  A  G  A  A  G  -3′ and antisense 5′-T  T  G  G-
T  A  T  C  G  G  C  A  T  C  C  T  C  A  G  C  -3′.
Immunostaining
The IFMs were dissected from the thorax with the help of ﬁ  ne forceps and 
needles in a drop of PBS. The entire muscle preparation was ﬁ  xed in 4% 
paraformaldehyde, and the ﬁ  bers were partially teased apart with nee-
dles. Immunoﬂ  uorescence was performed following established protocols. 
Certain preparations were also stained for ﬁ  lamentous actin by adding 
1 μM FITC-conjugated phalloidin (Sigma-Aldrich) 20 min before the second-
ary antibody incubation was completed. Images were taken using either a 
TCS SP2 laser scanning confocal microscope or a DM6000 microscope 
(both Leica), and assembled using Photoshop (Adobe). The Leica Confocal 
Scanner is interfaced with Leica Confocal Software, and the DM6000 
  microscope is interfaced with Volocity software. Images were captured 
at room temperature using a 62× oil immersion objective.
YFP-dSMN localization
Wild-type and transgenic thoracic muscles were dissected in a drop of 
phosphate-buffered saline (PBS) and ﬁ   xed in 4% paraformaldehyde. 
  Certain preparations were stained with 1 μM TRITC-phalloidin for 20 min 
to reveal ﬁ   lamentous actin. Teased myoﬁ   brils were washed in PBS and 
mounted in antifade (50% glycerol and 2.3% 1,4-diazobicyclo-2,2,2-
  octane). Images were obtained using a TCS SP2 laser scanning confocal 
microscope or DM6000 microscope, and assembled using Photoshop.
Motoneuron staining
Hemithoraces were generated by freezing in liquid nitrogen and dissecting 
with a razor blade along the central axis of the body. The bisection was 
slightly offset from the midline, so as to preserve the other half of the thorax 
intact. Tissues were then processed for immunostaining essentially as previ-
ously described (Hebbar and Fernandes, 2004). During ﬁ  xation, IFMs of 
the bisected side were ﬂ  ipped over to expose the contralateral hemithorax. 
The routing of the primary axons and the number of secondary branches 
was quantitated as described in the text.
Analysis of IFMs
Hemithoraces were prepared as described in the previous section, and the 
thoraces were observed and imaged under bright-ﬁ  eld optics, with or with-
out counterstaining with safranin for contrast. Analysis of muscles using 
plane-polarized optics was performed essentially as previously described 
(Nongthomba and Ramachandra, 1999).
Preparation and staining of mouse myoﬁ  brils
Mouse skeletal myoﬁ   brils were prepared by the method of Knight and 
  Trinick (1982). In brief, hind leg skeletal muscles were depleted of calcium 
by incubating in an EGTA–Ringer’s solution overnight at 4°C. The sample 
was placed in rigor buffer and homogenized using a glass Dounce tissue 
grinder. The homogenate was spun (2,000 g for 5 min) and washed in 
  repeated cycles until a pure preparation of myoﬁ  brils (as monitored by 
phase-contrast microscopy) was obtained. Puriﬁ  ed  myoﬁ   brils were ad-
sorbed onto a gelatin-coated slide and subjected to immunoﬂ  uorescence 
analysis using standard protocols. Note that for dual staining of Smn 
and α-actinin, mouse monoclonal antibodies targeting a-actinin were incu-
bated with the puriﬁ  ed myoﬁ  brils, followed by incubation with second-
ary antibodies conjugated to Alexa Fluor 594. After extensive washes, JCB • VOLUME 176 • NUMBER 6 • 2007  840
the preparations were incubated with FITC-conjugated monoclonal anti-
SMN antibodies.
Online supplemental material
Fig. S1 shows the analysis of snRNA and snRNP levels in wild-type and 
mutant animals. Fig. S2 shows the amino acid sequence of D.   melanogaster 
α-actinin that was covered by mass spectrometric analysis of the band 
shown in Fig. 5 A. Videos 1 and 2 show the ﬂ  ight behavior of wild-type 
and E33 mutant adult ﬂ  ies, respectively. The online version of this article is 
available at http://www.jcb.org/cgi/content/full/jcb.200610053/DC1.
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